
Overview
Aditya Halthore, MD, serves as Assistant Professor in the Department of Radiation Oncology and Molecular Radiation Sciences and Director of Safety and Quality at the Johns Hopkins University School of Medicine. Listen to Dr. Halthore's On Target podcast episode to learn more about his work. Dr. Halthore is an expert in proton therapy and specializes in genitourinary and thoracic cancers. His specific interests include prostate, bladder, lung, esophageal, and thymic cancers, and he is committed to developing personalized treatment strategies for every patient. Dr. Halthore was previously recognized as a Howard Hughes Medical Institute (HHMI)/National Institutes of Health (NIH) Scholar and his research interests include grant funded clinical trials focused on the novel utilization of radiation and imaging techniques, such as spatial fractionation (proton GRID) therapy for the treatment of bulky cancers. He is also involved in using dual-energy CT and functional MRI studies that aim to improve functional radiation planning and the assessment of radiation-induced changes. As an educator, Dr. Halthore serves as Course Director for the Johns Hopkins Proton Therapy Certificate Program. He actively participates in student, resident, and fellow lectureship and mentorship across the Johns Hopkins health system. Dr. Halthore participates in several national-level initiatives including as a member of the American Society of Therapeutic Radiation Oncology (ASTRO) Guidelines Subcommittee and as a board member and ASTRO liaison to the Medical Dosimetry Certification Board (MDCB).
Dr. Halthore is highly rated in 9 conditions, according to our data. His top areas of expertise are Prostate Cancer, Small Cell Lung Cancer (SCLC), Marginal Zone Lymphoma (MZL), and Familial Prostate Cancer.
His clinical research consists of co-authoring 22 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Residency
Specialties
Licenses
Board Certifications
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5255 Loughboro Road Northwest, Washington, DC 20016
300 Mason Lord Drive, Kimmel Cancer Center, Baltimore, MD 21224
5255 Loughboro Road Northwest, Washington, DC 20016
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Kevin Camphausen is a Radiation Oncologist in Bethesda, Maryland. Dr. Camphausen is highly rated in 5 conditions, according to our data. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Gliomatosis Cerebri.
Sidney Kimmel Comprehensive Cancer Center
Dr. Kleinberg specializes in the radiation treatments, including stereotactic radiosurgery, of brain and spinal tumors. Areas of research include both tumors arising in the central nervous system and tumors metastasizing from other locations. He also specializes in the treatment of esophageal tumors and has led national clinical trials in both therapy of brain tumors as well as esophageal cancer. Dr. Kleinberg has been recently named in the US News and World Report list of top 1% of doctors in his specialty. He is the co-chair of the Eastern Cooperative Oncology Group Brain Tumor Working Group, Vice-Chair of the NCI Cooperative Group Steering Committee for Esophageal and Gastric Tumors, and is a member of the NCI Cooperative Group Steering Committee for Gastrointestinal Tumors. He is also on the American College of Radiation Oncology Neurologic Cancer Practice Accreditation Team. Make A Gift. Dr. Kleinberg is highly rated in 28 conditions, according to our data. His top areas of expertise are Glioblastoma, Astrocytoma, Brain Tumor, Glioma, and Hepato-Pancreato-Biliary Surgery.
Sibley Memorial Hospital
Curtiland Deville, MD, is the Medical Director of the Johns Hopkins Proton Therapy Center, Clinical Director of Radiation Oncology at Sibley Memorial Hospital, co-director of the Kimmel Cancer Center Prostate Multidisciplinary Clinic at Sibley Memorial Hospital and an Associate Professor at the Johns Hopkins University School of Medicine. Dr. Deville is an expert in proton therapy and a leader in several institutional and national clinical trials. He treats genitourinary malignancies, including prostate cancer, and soft tissue sarcomas, and is dedicated to creating individualized treatment plans for each patient. His research interests involve better targeting tumors through proton and photon therapies and reducing radiation to healthy tissues. He analyzes toxicity rates with modern radiation techniques and uses the most advanced technology for his patients’ care. Dr. Deville is also a Senior Editor for Advances in Radiation Oncology, as well as a reviewer for several journals that focus on radiation oncology. He is an expert on physician workforce diversity and widely published in the field. He is the immediate past Chair of the American Society of Radiation Oncology's Committee on Health Equity, Diversity and Inclusion and Chair of the American Society of Clinical Oncology’s Diversity in Oncology Subcommittee. LinkedIn https://www.linkedin.com/in/curtiland-deville-37133136. Dr. Deville is highly rated in 7 conditions, according to our data. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Adult Soft Tissue Sarcoma, Myxoid Liposarcoma, and Prostatectomy.
Frequently Asked Questions about Dr. Aditya N. Halthore
How do I make an appointment with Dr. Aditya N. Halthore?
You can book an appointment with Dr. Aditya N. Halthore by calling their office at 410-502-8000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Aditya N. Halthore a top-rated expert for Prostate Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Aditya N. Halthore is classified as an Distinguished expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Aditya N. Halthore specialize in?
While Dr. Aditya N. Halthore is a Radiation Oncology, they have specific expertise in Prostate Cancer, Small Cell Lung Cancer (SCLC), and Marginal Zone Lymphoma (MZL). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.
Does Dr. Aditya N. Halthore participate in research or clinical trials?
Yes. Dr. Aditya N. Halthore has published 22 articles and abstracts on conditions like Prostate Cancer. You can view a list of Dr. Aditya N. Halthore's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Aditya N. Halthore accept my insurance?
Dr. Aditya N. Halthore accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 410-502-8000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Prostate CancerDr. Halthore isDistinguished. Learn about Prostate Cancer.
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- Breast CancerDr. Halthore isAdvanced. Learn about Breast Cancer.
- Familial Prostate CancerDr. Halthore isAdvanced. Learn about Familial Prostate Cancer.
- Lung AdenocarcinomaDr. Halthore isAdvanced. Learn about Lung Adenocarcinoma.
- Marginal Zone Lymphoma (MZL)Dr. Halthore isAdvanced. Learn about Marginal Zone Lymphoma (MZL).
- Pleuropulmonary BlastomaDr. Halthore isAdvanced. Learn about Pleuropulmonary Blastoma.
- Experienced
- Adult Soft Tissue SarcomaDr. Halthore isExperienced. Learn about Adult Soft Tissue Sarcoma.
- EGFR Positive Lung CancerDr. Halthore isExperienced. Learn about EGFR Positive Lung Cancer.
- Fibrodysplasia Ossificans ProgressivaDr. Halthore isExperienced. Learn about Fibrodysplasia Ossificans Progressiva.
- Large-Cell Lung CarcinomaDr. Halthore isExperienced. Learn about Large-Cell Lung Carcinoma.
- Laryngeal CancerDr. Halthore isExperienced. Learn about Laryngeal Cancer.
- Lung CancerDr. Halthore isExperienced. Learn about Lung Cancer.

